Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan
· Delayed Price · Currency is TWD 50.40
+0.45 (0.90%)
Apr 29, 2026, 1:30 PM CST
Senhwa Biosciences Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -264.77 | -293.75 | -296.31 | -349.63 | -329.26 | Upgrade
|
| Depreciation & Amortization | 12.11 | 12.1 | 10.73 | 7.11 | 6.23 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.16 | -8.68 | -8.04 | - | - | Upgrade
|
| Stock-Based Compensation | 1.15 | - | -0.64 | 1.03 | 3.47 | Upgrade
|
| Other Operating Activities | -1.39 | -0.72 | -1.07 | -0.25 | -7.91 | Upgrade
|
| Change in Accounts Receivable | 0.03 | 9.99 | -9.87 | 0.19 | -0.19 | Upgrade
|
| Change in Accounts Payable | 12.16 | -10.83 | 9.74 | -52.3 | 27.19 | Upgrade
|
| Change in Other Net Operating Assets | -1.59 | -2.34 | 1.07 | -6.12 | 0.41 | Upgrade
|
| Operating Cash Flow | -248.46 | -294.22 | -294.4 | -399.97 | -300.05 | Upgrade
|
| Capital Expenditures | -0.28 | -1.95 | -4.61 | -0.37 | -0.24 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.17 | - | -0.16 | Upgrade
|
| Investment in Securities | 6.16 | 8.68 | 8.04 | - | - | Upgrade
|
| Other Investing Activities | -0.06 | -0.02 | -0.48 | -0.22 | 0.55 | Upgrade
|
| Investing Cash Flow | 5.82 | 6.71 | 2.79 | -0.59 | 0.15 | Upgrade
|
| Long-Term Debt Repaid | -9.34 | -8.73 | -8.83 | -6.31 | -4.93 | Upgrade
|
| Net Debt Issued (Repaid) | -9.34 | -8.73 | -8.83 | -6.31 | -4.93 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 6.81 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -13.24 | -36.12 | Upgrade
|
| Financing Cash Flow | -9.34 | -8.73 | -8.83 | -19.55 | -34.24 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.2 | 3.4 | 0.11 | 6.67 | -1.85 | Upgrade
|
| Net Cash Flow | -254.19 | -292.84 | -300.33 | -413.44 | -336 | Upgrade
|
| Free Cash Flow | -248.74 | -296.17 | -299 | -400.34 | -300.29 | Upgrade
|
| Free Cash Flow Margin | -23246.45% | -29617.30% | -29900.10% | -40034.00% | -54597.64% | Upgrade
|
| Free Cash Flow Per Share | -2.79 | -3.32 | -3.35 | -4.49 | -3.35 | Upgrade
|
| Cash Interest Paid | 0.75 | 0.66 | 0.54 | 0.54 | 0.53 | Upgrade
|
| Cash Income Tax Paid | 1.79 | 1.62 | 1.87 | 1.36 | -1.32 | Upgrade
|
| Levered Free Cash Flow | -148.9 | -185.82 | -176.66 | -273.62 | -177.76 | Upgrade
|
| Unlevered Free Cash Flow | -148.43 | -185.41 | -176.33 | -273.28 | -177.43 | Upgrade
|
| Change in Working Capital | 10.6 | -3.17 | 0.94 | -58.23 | 27.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.